Internal antiparasitic as oral tablet
The information available on this page complies with the legislation and texts in vigour in Spain. For all other countries, please refer to the specific local information or contact our Export Department for more information.
*The content of this page is purely informative. For a correct use of the products, please refer to the indications in the Summary of product characteristics..
Quick product information
Active ingredient(s) | Posology* | Waiting time | Packaging |
---|---|---|---|
Prazicuantel Febantel Pirantel | Oral administration | Not applicable | 20 tablets. |
Country Availability
Portugal, Spain.
If your country is not listed, please contact our export team.
Active ingredient(s)
Prazicuantel……………………………………………………………………………………………. 50 mg / Co
Pirantel (equivalent to 144 mg of pirantel embonate) …………………………….50 mg/Tablet
Febantel …………………………………………………………………………………………………..150 mg/Tablet
Indications
In dogs: treatment of mixed nematode or cestode infections of the following species:
Nematodes:
Ascarids: Toxocara canis, Toxascaris leonina (adults and advanced immature forms).
Ankylostomes: Uncinaria stenocephala, Ancylostoma caninum (adults).
Tricuros: Trichuris vulpis (adults).
Cestodes:
Tapeworms: Echinococcus spp (Echinococcus granulosus, Echinococcus multilocularis), Taenia spp. (Taenia hydatigena, Taenia pisiformis, Taenia taeniaeformis), Dipylidium caninum (adults and immature forms).
Contra-indications
Do not use simultaneously with piperazine compounds.
Do not use if hypersensitive to active substances or any excipient.
Special precautions
The use of the veterinary drug is not recommended in dogs for the first 4 weeks
gestation. Do not exceed the recommended dose for treatment in pregnant dogs.
Posology
1 tablet/10 kg p.v.
Waiting time
Not applicable
Packaging
Container with 20 and 100 tablets.
With veterinary prescription.
Registry no.: 3082 ESP